Strategies for the use of Ginkgo biloba extract, EGb 761(®), in the treatment and management of mild cognitive impairment in Asia: Expert consensus

BACKGROUND: Mild cognitive impairment (MCI) is a neurocognitive state between normal cognitive aging and dementia, with evidence of neuropsychological changes but insufficient functional decline to warrant a diagnosis of dementia. Individuals with MCI are at increased risk for progression to dementi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kandiah, Nagaendran, Chan, Yee Fai, Chen, Christopher, Dasig, Darwin, Dominguez, Jacqueline, Han, Seol‐Heui, Jia, Jianping, Kim, SangYun, Limpawattana, Panita, Ng, Li‐Ling, Nguyen, Dinh Toan, Ong, Paulus Anam, Raya‐Ampil, Encarnita, Saedon, Nor'izzati, Senanarong, Vorapun, Setiati, Siti, Singh, Harjot, Suthisisang, Chuthamanee, Trang, Tong Mai, Turana, Yuda, Venketasubramanian, Narayanaswamy, Yong, Fee Mann, Youn, Yong Chul, Ihl, Ralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Guideline
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816207/
https://www.ncbi.nlm.nih.gov/pubmed/33352000
http://dx.doi.org/10.1111/cns.13536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816207/
https://www.ncbi.nlm.nih.gov/pubmed/33352000
http://dx.doi.org/10.1111/cns.13536

Ejemplares similares